Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6534503 | Melanocortin receptor-3 ligands to treat sexual dysfunction | Kevin C. Dines, Timothy C. Gahman, Beverly E. Girten, Douglas L. Hitchin, Kevin R. Holme +4 more | 2003-03-18 |
| 6284735 | HP-3228 and related peptides to treat sexual dysfunction | Beverly E. Girten | 2001-09-04 |
| 6245738 | Cytokine restraining agents | Mark J. Suto, Beverly E. Girten, Richard A. Houghten, Costas C. Loullis | 2001-06-12 |
| 5965536 | Methods of inhibiting CXC intercrine molecules | Allen Barry Cohen, deceased, Edmund Miller, Shinichiro Hayashi, Anna Kurdowska | 1999-10-12 |
| 5888978 | Method for reducing the severity of gastro-intestinal damage | Beverly E. Girten, Paul Omholt | 1999-03-30 |
| 5888969 | Use of cytokine restraining agents to treat inflammatory bowel disease | Beverly E. Girten | 1999-03-30 |
| 5786332 | Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels | Beverly E. Girten, Richard A. Houghten, Costas C. Loullis, Mark J. Suto | 1998-07-28 |
| 5760001 | Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels | Beverly E. Girten, Richard A. Houghten, Costas C. Loullis, Mark J. Suto | 1998-06-02 |
| 5741774 | Use of a cytokine regulatory agent to treat rheumatoid arthritis | Beverly E. Girten | 1998-04-21 |
| 5726156 | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels | Beverly E. Girten, Ali Andalibi, Amaresh Basu, Patrick C. Fagan, Richard A. Houghten +4 more | 1998-03-10 |
| 5658889 | Method and compounds for aica riboside delivery and for lowering blood glucose | Harry E. Gruber, Clinton E. Browne, Bheemarao G. Ugarkar, Jack W. Reich, Ernest K. Metzner +1 more | 1997-08-19 |
| 5643967 | Growth promotion | David B. Anderson, Klaus K. Schmiegel, Edward L. Veenhuizen | 1997-07-01 |
| 5597843 | Use of a substituted 1,3-benzodioxole to reduce a wasting condition | Beverly E. Girten | 1997-01-28 |
| 5460605 | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist | Clinton E. Browne | 1995-10-24 |
| 5420109 | Cytokine restraining agents | Mark J. Suto, Beverly E. Girten, Richard A. Houghten, Costas C. Loullis | 1995-05-30 |
| 5395970 | 1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanol | Clinton E. Browne | 1995-03-07 |
| 5286252 | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist | Clinton E. Browne | 1994-02-15 |
| 5234404 | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist | Clinton E. Browne | 1993-08-10 |
| 5108363 | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist | Clinton E. Browne | 1992-04-28 |
| 4946848 | Method of treating pruritus with nalmefene and clonidine | J. R. Thornton | 1990-08-07 |
| 4849453 | Growth promotion | David B. Anderson, Klaus K. Schmiegel, Edward L. Veenhuizen | 1989-07-18 |
| 4774230 | Glucuronic acid derivatives of opioid antagonists | Ross Dixon, Maciej M. Smulkowski | 1988-09-27 |
| 4562206 | Orally effective inotropic compounds | — | 1985-12-31 |
| 4511570 | Senile dementia treatment | — | 1985-04-16 |
| 4483860 | Hyperkinetic child treatment agent | — | 1984-11-20 |